Columbia biomedical engineers are collaborating with orthopedic surgeons to build a living replacement knee to be tested in clinical trials within five years.
Columbia genome engineers are designing a CRISPR-based gene therapy with potential to prevent blindness in anyone with retinitis pigmentosa, a condition caused by more than 80 different genes.
An analysis of more than 40,000 primary sensory neurons in the skin has found multiple different types, each sensing a more complex range of stimuli than previously assumed.
A recent rise in a rare lymphoma has been linked to breast implants, but Columbia researchers have found that the risk is extremely low among women who have reconstructive surgery after mastectomy.
Columbia's Clinical Innovation Lab, a hub that helps doctors develop new technologies to improve patient care, has already funded five projects. Yours could be next.
The diminished power of the immune system in older adults is usually blamed on the aging process. A new study shows that decades of inhaled particulates due to air pollution also take a toll.
An implantable pump that has the potential to transform brain cancer treatment was found safe and effective in people in a study at Columbia University.
Ghosh was elected for his elected for his pioneering studies of the immune system and establishing strategies for the treatment of inflammatory diseases and cancer.
Columbia will award the 2022 Louisa Gross Horwitz Prize to Karl Deisseroth, Peter Hegemann, and Gero Miesenböck, for research that laid the foundation for the field of optogenetics.
A study of mice found that dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease, pre-diabetes, and weight gain.